- High doses of rotigotine transdermal patch: results of an open-label,…
Number of the records: 1  

High doses of rotigotine transdermal patch: results of an open-label, dose-escalation trial in patients with advanced-stage, idiopathic Parkinson disease

  1. High doses of rotigotine transdermal patch: results of an open-label, dose-escalation trial in patients with advanced-stage, idiopathic Parkinson disease = Vysoké dávky rotigotinu v transdermální náplasti: výsledky otevřené studie s eskalací dávky u pacientů v pokročilém stadiu idiopatické Parkinsonovy choroby / Ivan Rektor. Neurológia pre prax Roč. 11, č. 1 (2010), s. 69
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.